EUVIMEDEUVIMED entdecken
Crossref

Review of the CHA₂DS₂-VASc Score

Rahul Aggarwal

Evidence to Action: Official Journal of MDCalc · 15.04.2026 · 022026 (01)

DOI: 10.65357/001c.160263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Evidence to Action: Official Journal of MDCalc, online erschienen am 15.04.2026. Verfasst von Rahul Aggarwal.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The CHA₂DS₂-VASc score is a validated clinical tool for estimating the annual risk of thromboembolic and ischemic stroke in patients with non-valvular atrial fibrillation. It was developed among patients not taking anticoagulation. It refines the earlier CHADS₂ score by incorporating additional risk factors to identify low-risk patients who may not require anticoagulation. The score guides shared decision-making regarding oral anticoagulation.

Zitieren

APA

Aggarwal, R. (2026). Review of the CHA₂DS₂-VASc Score. Evidence to Action: Official Journal of MDCalc, 022026(01). https://doi.org/10.65357/001c.160263

Vancouver

Aggarwal R. Review of the CHA₂DS₂-VASc Score. Evidence to Action: Official Journal of MDCalc. 2026;022026(01). doi:10.65357/001c.160263

BibTeX
@article{Aggarwal2026,
  author = {Aggarwal, Rahul},
  title = {Review of the CHA₂DS₂-VASc Score},
  journal = {Evidence to Action: Official Journal of MDCalc},
  year = {2026},
  volume = {022026},
  number = {01},
  doi = {10.65357/001c.160263}
}
Kostenlos starten →